BeStock  
Stocks › Biotechnology › AUPH

Aurinia Pharmaceuticals AUPH

US equityMarket cap rank #2690Biotechnology
$14.70 −$0.19 (-1.28%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $14.64 -0.41%
Open$14.69
Prev close$14.89
Day range$14.63 – $14.97
Volume1.34M
Market cap$1.97B
P/E (TTM)6.4
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$19.00+29.3% vs. price
  • Buy 67%
  • Hold 33%
Low $18.00Now $14.70Avg $19.00High $21.00

Recent rating changes

The last 20 actions on file set price targets from $15.00 to $21.00, averaging $17.25.

DateFirmRatingTarget
2 Nov 2026 Bloom Burton BUY $21.00
30 Oct 2026 RBC Capital HOLD $18.00
21 Oct 2026 TD Cowen BUY $18.00
20 Aug 2026 Bloom Burton BUY $21.00
19 Aug 2026 TD Cowen BUY $17.00
6 Aug 2026 TD Cowen BUY $17.00
20 Jul 2026 TD Cowen BUY $17.00
6 Jul 2026 TD Cowen BUY $17.00
7 May 2026 TD Cowen BUY $17.00
31 Mar 2026 Bloom Burton HOLD $15.00
30 Mar 2026 TD Cowen BUY $17.00
27 Feb 2026 Bloom Burton HOLD $15.00
27 Feb 2026 H.C. Wainwright BUY $17.00
27 Feb 2026 RBC Capital HOLD $15.00
26 Feb 2026 TD Cowen BUY $17.00
3 Dec 2025 Leerink Partners HOLD $16.00
7 Nov 2025 Jefferies BUY $21.00
5 Nov 2025 H.C. Wainwright BUY $17.00
4 Nov 2025 TD Cowen BUY $17.00
4 Nov 2025 RBC Capital HOLD $15.00

Discussion

No comments yet — be the first to weigh in on AUPH.

Sign in to join the discussion.

Scroll to Top